planet biopharmaceuticals in
(PBPH:OTC US)
planet biopharmaceuticals in (PBPH) Snapshot
|
Open
--
|
Previous Close
$0.0012
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
07/25/12 - $0.0050
|
52 Week Low
11/13/12 - $0.0006
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
$-0.24
|
Shares Outstanding
4.0M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
planet biopharmaceuticals in (PBPH) Related Businessweek News
No Related Businessweek News Foundplanet biopharmaceuticals in (PBPH) Details
Planet Biopharmaceuticals, Inc. engages in the design, manufacture, sale, and distribution of allergen avoidance products in the United States. Its products include bedding products under Allergy Control brand; and air filters under Allergy Free brand. The company also markets a range of bedding products; carpet cleaning and laundry products; vacuums; air cleaners and air filters; sinus and breathing aids; respiratory products; dehumidifiers; mold prevention and house cleaning products; pet allergy products; and certain allergy-related skin and hair care products. Planet Biopharmaceuticals distributes its products through catalog direct mail, as well as through physician offices, the Internet, and retail channel. Planet Biopharmaceuticals, Inc. was formerly known as Planet Polymer Technologies, Inc. and it changed its name to Planet Biopharmaceuticals, Inc. in 2008. The company was incorporated in 1991 and is based in Ridgefield, Connecticut.
Last Reported Date: 03/23/07
planet biopharmaceuticals in (PBPH) Key Developments
Planet Biopharmaceuticals, Inc. and its wholly owned Subsidiaries announced that Theron (Ted) E. Odlaug has been named as the company's Executive Chairman and will assume the additional role of Chief Executive Officer on August 29, 2011. Odlaug will replace William (Bill) Goldberg, who has joined MediMedia USA, Inc. as Chief Executive Officer. Goldberg will remain on Planet's board of directors as an independent director. Odlaug will be responsible for day-to-day operations and corporate strategy. From 2008 until January of 2011 Ted was President and CEO of CyDex Pharmaceuticals, Inc. when the company was sold under Ted's leadership to Ligand Pharmaceuticals, Inc. Prior to CyDex, Ted served as Managing Partner of EIR Healthcare Advisors, LLC.
| Recently Viewed | |||
| PBPH:US | $0.00 USD | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for PBPH. | |||
| View Industry Companies | |||
Industry Analysis
PBPH
Industry Average
| Valuation | PBPH | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.0x |
|
| Price/Book | 0.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact PLANET BIOPHARMACEUTICALS IN, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
